275 related articles for article (PubMed ID: 4260668)
21. [Dynamics of specific changes in recurrences of pulmonary tuberculosis in relation to chemotherapy schedules].
Bobarykin VS
Probl Tuberk; 1991; (10):53-5. PubMed ID: 1788233
[No Abstract] [Full Text] [Related]
22. Rifampin-isoniazid compared with PAS-isoniazid-streptomycin in initial treatment of pulmonary tuberculosis. A controlled cooperative trial.
Boman G
Chest; 1972 Jun; 61(6):533-8. PubMed ID: 5032151
[No Abstract] [Full Text] [Related]
23. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
Dubra F
Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016
[No Abstract] [Full Text] [Related]
24. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
Trébucq A; Rieder HL
Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
[No Abstract] [Full Text] [Related]
25. [Results of 6-month and 9-month treatments with rifampin, isoniazid and ethambutol in cases of newly detected tuberculosis].
Szymanski A; Gaik A
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(3):181-3. PubMed ID: 6273991
[No Abstract] [Full Text] [Related]
26. Drug resistant pulmonary tuberculosis treated with ethambutol and rifampicin in North East England.
Somner AR; Selkon JB; Walton M; White AB
Tubercle; 1973 Jun; 54(2):141-5. PubMed ID: 4203159
[No Abstract] [Full Text] [Related]
27. Side effects of rifampicin. A clinical study.
Mattson K
Scand J Respir Dis Suppl; 1973; 82():1-52. PubMed ID: 4518740
[No Abstract] [Full Text] [Related]
28. A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council investigation.
Tubercle; 1974 Mar; 55(1):1-27. PubMed ID: 4283482
[No Abstract] [Full Text] [Related]
29. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
[TBL] [Abstract][Full Text] [Related]
30. Rifampin.
Schonell M; Dorken E; Grzybowski S
Can Med Assoc J; 1972 Apr; 106(7):783-6. PubMed ID: 4622757
[TBL] [Abstract][Full Text] [Related]
31. [Fever and thin-walled cavitary lung lesions].
Ramos A; Daza R; Alvarez-Espejo T; Guzmán MF
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):363-4. PubMed ID: 19419797
[No Abstract] [Full Text] [Related]
32. Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis.
Kohno S; Koga H; Kaku M; Maesaki S; Hara K
Chest; 1992 Dec; 102(6):1815-8. PubMed ID: 1446494
[TBL] [Abstract][Full Text] [Related]
33. Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial.
Newman R; Doster B; Murray FJ; Ferebee S
Am Rev Respir Dis; 1971 Apr; 103(4):461-76. PubMed ID: 4994459
[No Abstract] [Full Text] [Related]
34. Rapid oral tolerance induction to isoniazid and pyrazinamide and controlled administration of ethambutol: clinical case.
Rodrigues Carvalho S; Silva I; Leiria-Pinto P; Rosado-Pinto J
Allergol Immunopathol (Madr); 2009; 37(6):336-8. PubMed ID: 19875222
[No Abstract] [Full Text] [Related]
35. Daily and intermittent short-course regimens in the original treatment of pulmonary tuberculosis. Preliminary results. Cooperative comparative clinical study in Poland.
Zierski M
Scand J Respir Dis Suppl; 1978; 102():48-52. PubMed ID: 278215
[No Abstract] [Full Text] [Related]
36. Rifampin and isoniazid in previously untreated patients with pulmonary tuberculosis.
Lees AW; Allan GW; Smith J; Tyrrell WF; Fallon RJ
Am Rev Respir Dis; 1972 Jan; 105(1):132-4. PubMed ID: 5007611
[No Abstract] [Full Text] [Related]
37. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
Masztalerz J
Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043
[No Abstract] [Full Text] [Related]
38. Rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS in the initial treatment of pulmonary tuberculosis. A controlled multicenter clinical trial.
Tousek J; Votruba R
Chemotherapy; 1974; 20(3):183-200. PubMed ID: 4605071
[No Abstract] [Full Text] [Related]
39. Treatment of isoniazid-resistant pulmonary tuberculosis with ethambutol, rifampicin and capreomycin: a co-operative study in England and Wales.
Andrews RH; Jenkins PA; Marks J; Pines A; Selkon JB; Somner AR
Tubercle; 1974 Jun; 55(2):105-13. PubMed ID: 4143450
[No Abstract] [Full Text] [Related]
40. A trial of intermittent rifampicin and ethambutol in retreatment regimens.
Zierski M
Scand J Respir Dis Suppl; 1973; 84():132-5. PubMed ID: 4522067
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
